Myocardial perfusion reserve of kidney transplant patients is well preserved

Johanna Päivärinta1,2, Kaj Metsärinne3, Eliisa Löyttyniemi4

  • 1Department of Medicine, Division of Nephrology, Turku University Hospital, PL 52, Kiinamyllynkatu 4-8, 20521, Turku, Finland. johanna.paivarinta@fimnet.fi.

EJNMMI Research
|February 11, 2020
PubMed

Insights

Kidney transplant patients with early-stage chronic kidney disease (CKD) show preserved stress myocardial perfusion (MP). Increased resting MP, likely due to sympathetic overactivation, explains reduced myocardial perfusion reserve (MPR) in these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Nuclear Medicine

Background:

  • Chronic kidney disease (CKD) is linked to endothelial dysfunction and heightened cardiovascular mortality.
  • Endothelial dysfunction can be assessed by measuring myocardial perfusion reserve (MPR), a ratio of stress and rest myocardial perfusion (MP).
  • MPR indicates the vascular bed's capacity for increased perfusion and microvascular responsiveness.

Purpose of the Study:

  • To evaluate MPR in kidney transplant recipients with early-stage CKD (stages 2-3).
  • To compare MPR between kidney transplant patients and healthy controls using quantitative positron emission tomography (PET).

Main Methods:

  • Utilized quantitative [15O]H2O positron emission tomography (PET) to measure myocardial perfusion.
  • Assessed myocardial perfusion reserve (MPR) by calculating the ratio of stress to rest myocardial perfusion (MP).
  • Corrected basal MP for cardiac workload using the rate-pressure product (RPP).

Main Results:

  • Kidney transplant patients exhibited significantly higher resting MP compared to healthy controls (p=0.0015).
  • After correcting for cardiac workload, the difference in resting MP between groups disappeared (p=0.55).
  • Stress MP and corrected MPR (MPRcorr) did not differ significantly between kidney transplant patients and controls (p=0.53 and p=0.8, respectively).

Conclusions:

  • Myocardial perfusion during stress is maintained in kidney transplant patients with CKD stages 2-3.
  • The observed reduction in MPR is attributed to elevated resting MP.
  • Increased resting MP is likely associated with heightened cardiac workload stemming from sympathetic overactivation in kidney transplant recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
272
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
238
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
263